We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
International Flavors (IFF) Q3 Earnings & Sales Top Estimates
Read MoreHide Full Article
International Flavors & Fragrances Inc. (IFF - Free Report) reported adjusted earnings of $1.36 per share in third-quarter 2022, beating the Zacks Consensus Estimate of $1.30. The bottom line declined 7% from the year-ago quarter.
Including one-time items, the company reported a loss per share of $8.60 compared with the prior-year quarter’s earnings per share of 76 cents.
International Flavors’ net sales came in at $3,063 million in the September-end quarter, flat year over year. The top line surpassed the Zacks Consensus Estimate of $3,026 million. During the quarter, currency-neutral sales were up 10%, aided by double-digit growth in Nourish and Pharma Solutions.
International Flavors & Fragrances Inc. Price, Consensus and EPS Surprise
During the reported quarter, International Flavors’ adjusted cost of goods sold was up 4% year over year to $2,062 million. Adjusted gross profit moved down 7% year over year to $1,001 million. The adjusted gross margin came in at 32.7% compared with 35.2% in the year-ago quarter.
Research and development expenses declined 7% year over year to $145 million. Adjusted selling and administrative expenses were down 6% year on year to $355 million during the third quarter. Adjusted operating EBITDA came in at $612 million, down 6% from the prior-year quarter’s $648 million.
On a comparable basis, currency-neutral adjusted operating EBITDA grew 3% from the prior year as strong pricing actions and productivity gains helped offset the impact of lower volumes. Adjusted operating EBITDA margin was 20% compared with the year-ago quarter’s 21%.
Segmental Performances
Revenues in the Nourish segment climbed 3% year over year to $1.703 million during the September-end quarter. Adjusted operating EBITDA was $287 million, down 12% year over year.
Revenues generated in the Health & Bioscience segment were $495 million compared with the year-earlier quarter’s $510 million. Adjusted operating EBITDA was $139 million in the quarter compared with $149 million in the prior-year quarter.
The scent segment’s revenues came in at $591 million compared with the year-ago quarter’s $580 million. Adjusted operating EBITDA declined 8% year over year to $119 million.
Revenues in Pharma Solutions were $257 million in the third quarter, gaining 22% year over year. Adjusted operating EBITDA soared 73% year over year to $69 million.
Financial Position
International Flavors had cash and cash equivalents of $538 million at the end of the third quarter, down from the $711 million witnessed at the end of 2021. Long-term debt was $10.3 billion at the third quarter’s end compared with $10.8 billion at 2021-end.
International Flavors utilized $189 million cash in operating activities in the first nine month period of 2022, down from the figure of $1,126 million in the prior-year period.
2022 Guidance
International Flavors now expect sales in fiscal 2022 to be between $12.4 billion and $12.5 billion, lower than the earlier projected range of $12.6 billion to $13 billion. This revision was mainly due to account for an unfavorable impact from foreign exchange and a more challenging operating environment. Foreign currency translation will likely affect sales growth by 5 percentage points (PP) and adjusted operating EBITDA growth by 6 PP.
Adjusted EBITDA is expected to come in near the low end of the previously stated range of $2.5 billion to $2.6 billion. The adjusted EBITDA margin is projected to grow at the low end of the band of 4-8% on a currency-neutral basis. Currency-neutral sales growth for the year is expected to be around 9 to 10%, down from 9 to 12% expected earlier.
Price Performance
Image Source: Zacks Investment Research
In the past year, International Flavors’ shares have lost 37.1% compared with the industry’s decline of 42.3%.
Zacks Rank & Key Picks
International Flavors currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Consumer Staples sector are TreeHouse Foods (THS - Free Report) , Lamb Weston (LW - Free Report) and Medifast (MED - Free Report) .
TreeHouse Foods, which manufactures and distributes private-label foods and beverages, sports a Zacks Rank #1 (Strong Buy) at present. TreeHouse Foods has a trailing four-quarter earnings surprise of 45.2%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for THS’ current financial-year sales and EPS suggests growth of 16.8% and 15.1%, respectively, from the year-ago reported numbers.
Lamb Weston, a frozen potato product company, currently sports a Zacks Rank #1. LW has a trailing four-quarter earnings surprise of 47.3%, on average.
The Zacks Consensus Estimate for Lamb Weston’s current financial-year sales and earnings suggests growth of 14.6% and 45.7%, respectively, from the year-ago reported numbers.
Medifast, which manufactures and distributes weight loss, weight management, healthy living products and other consumable health and nutritional products, currently carries a Zacks Rank #2 (Buy). MED has a trailing four-quarter earnings surprise of 12.4%, on average.
The Zacks Consensus Estimate for Medifast’s current financial year sales EPS suggests a decline of 8.3% from the year-ago reported figures.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
International Flavors (IFF) Q3 Earnings & Sales Top Estimates
International Flavors & Fragrances Inc. (IFF - Free Report) reported adjusted earnings of $1.36 per share in third-quarter 2022, beating the Zacks Consensus Estimate of $1.30. The bottom line declined 7% from the year-ago quarter.
Including one-time items, the company reported a loss per share of $8.60 compared with the prior-year quarter’s earnings per share of 76 cents.
International Flavors’ net sales came in at $3,063 million in the September-end quarter, flat year over year. The top line surpassed the Zacks Consensus Estimate of $3,026 million. During the quarter, currency-neutral sales were up 10%, aided by double-digit growth in Nourish and Pharma Solutions.
International Flavors & Fragrances Inc. Price, Consensus and EPS Surprise
International Flavors & Fragrances Inc. price-consensus-eps-surprise-chart | International Flavors & Fragrances Inc. Quote
Operational Highlights
During the reported quarter, International Flavors’ adjusted cost of goods sold was up 4% year over year to $2,062 million. Adjusted gross profit moved down 7% year over year to $1,001 million. The adjusted gross margin came in at 32.7% compared with 35.2% in the year-ago quarter.
Research and development expenses declined 7% year over year to $145 million. Adjusted selling and administrative expenses were down 6% year on year to $355 million during the third quarter. Adjusted operating EBITDA came in at $612 million, down 6% from the prior-year quarter’s $648 million.
On a comparable basis, currency-neutral adjusted operating EBITDA grew 3% from the prior year as strong pricing actions and productivity gains helped offset the impact of lower volumes. Adjusted operating EBITDA margin was 20% compared with the year-ago quarter’s 21%.
Segmental Performances
Revenues in the Nourish segment climbed 3% year over year to $1.703 million during the September-end quarter. Adjusted operating EBITDA was $287 million, down 12% year over year.
Revenues generated in the Health & Bioscience segment were $495 million compared with the year-earlier quarter’s $510 million. Adjusted operating EBITDA was $139 million in the quarter compared with $149 million in the prior-year quarter.
The scent segment’s revenues came in at $591 million compared with the year-ago quarter’s $580 million. Adjusted operating EBITDA declined 8% year over year to $119 million.
Revenues in Pharma Solutions were $257 million in the third quarter, gaining 22% year over year. Adjusted operating EBITDA soared 73% year over year to $69 million.
Financial Position
International Flavors had cash and cash equivalents of $538 million at the end of the third quarter, down from the $711 million witnessed at the end of 2021. Long-term debt was $10.3 billion at the third quarter’s end compared with $10.8 billion at 2021-end.
International Flavors utilized $189 million cash in operating activities in the first nine month period of 2022, down from the figure of $1,126 million in the prior-year period.
2022 Guidance
International Flavors now expect sales in fiscal 2022 to be between $12.4 billion and $12.5 billion, lower than the earlier projected range of $12.6 billion to $13 billion. This revision was mainly due to account for an unfavorable impact from foreign exchange and a more challenging operating environment. Foreign currency translation will likely affect sales growth by 5 percentage points (PP) and adjusted operating EBITDA growth by 6 PP.
Adjusted EBITDA is expected to come in near the low end of the previously stated range of $2.5 billion to $2.6 billion. The adjusted EBITDA margin is projected to grow at the low end of the band of 4-8% on a currency-neutral basis. Currency-neutral sales growth for the year is expected to be around 9 to 10%, down from 9 to 12% expected earlier.
Price Performance
Image Source: Zacks Investment Research
In the past year, International Flavors’ shares have lost 37.1% compared with the industry’s decline of 42.3%.
Zacks Rank & Key Picks
International Flavors currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Consumer Staples sector are TreeHouse Foods (THS - Free Report) , Lamb Weston (LW - Free Report) and Medifast (MED - Free Report) .
TreeHouse Foods, which manufactures and distributes private-label foods and beverages, sports a Zacks Rank #1 (Strong Buy) at present. TreeHouse Foods has a trailing four-quarter earnings surprise of 45.2%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for THS’ current financial-year sales and EPS suggests growth of 16.8% and 15.1%, respectively, from the year-ago reported numbers.
Lamb Weston, a frozen potato product company, currently sports a Zacks Rank #1. LW has a trailing four-quarter earnings surprise of 47.3%, on average.
The Zacks Consensus Estimate for Lamb Weston’s current financial-year sales and earnings suggests growth of 14.6% and 45.7%, respectively, from the year-ago reported numbers.
Medifast, which manufactures and distributes weight loss, weight management, healthy living products and other consumable health and nutritional products, currently carries a Zacks Rank #2 (Buy). MED has a trailing four-quarter earnings surprise of 12.4%, on average.
The Zacks Consensus Estimate for Medifast’s current financial year sales EPS suggests a decline of 8.3% from the year-ago reported figures.